LBRX (LBRX) Stock Price & Analysis
LBRX (LBRX) rose 3.83% to USD 49.34 as of September 8, 2026 at 05:52 UTC, according to Nexqual real-time market data.
LBRX last closed at USD 49.34; the session ranged USD 47.47–49.87 on volume of 205,964 shares. Market capitalization is —, with a 52-week range of USD 13.36–50.16 (NGM). Source: Nexqual, September 8, 2026 at 05:52 UTC.
Key Statistics (as of September 8, 2026 at 05:52 UTC)
| Price | USD 49.34 |
|---|---|
| Change | ▲ 3.83% (up) |
| Previous Close | USD 49.34 |
| Open | USD 49.34 |
| Day Range | USD 47.47 – 49.87 |
| 52-Week Range | USD 13.36 – 50.16 |
| Volume | 205,964 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (LBRX)
Nexqual's technical model rates LBRX "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 05:52 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.88 (neutral) |
| vs SMA50 | Above (USD 40.51) |
| MACD | 2.17 (positive) |
From LBRX's Latest SEC 10-K Filing (filed 2026-03-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MPLT | MapLight Therapeutics, Inc. | USD 13.77 | ▲ 5.44% |
| MAZE | Maze Therapeutics, Inc. | USD 26.21 | ▼ 1.91% |
| EVMN | Evommune, Inc. | USD 12.27 | ▼ 1.68% |
| MBX | MBX Biosciences, Inc. | USD 61.72 | ▲ 1.36% |
| RAPP | Rapport Therapeutics, Inc. | USD 45.77 | ▼ 6% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:52 UTC. This page is informational and not investment advice.